Immunotherapy Industry, September 2014 Market Reports from Top Publishers

You might be interested in: cancer, therapeutics, medical equipment, more »


 
1-10 of 40 reports for Immunotherapy

Cancer Immunotherapy: immune checkpoint inhibitors, cancer vaccines, and adoptive T-cell therapies

Cancer Immunotherapy: immune checkpoint inhibitors, cancer vaccines, and adoptive T-cell therapies

  • $ 2 495
  • Industry report
  • September 2014
  • by CHI Insight Pharma Reports

... The future of adoptive immunotherapy for cancer outlook for cancer immunotherapy chapter 1: introductionthe early history of cancer immunotherapycytokines as immunomodulatory drugs ...

Immunovative Therapies, Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Immunovative Therapies, Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

... immunotherapy drug products for treatment of cancer and infectious disease. It offers products that include allovax, allostim, cryostim, indications and animations. Itl develops products based on mirror effect ...

Bellicum Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Bellicum Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

... Develops novel cellular immunotherapies for the treatment of cancer. The company is developing new modes of treatment that can be controlled precisely following their administration. It has two products ...

Immunomic Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Immunomic Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

... Vaccines to treat disease applications in human and animal health. Its vaccines include ara-lamp-vax, multi-lamp-vax, jrc-lamp-vax, hiv-lamp-vax, and grnvac1/2 cancer immunotherapy. The company develops ...

Juvaris BioTherapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Juvaris BioTherapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

... And commercialize adjuvanted vaccine and immunotherapy technology in the field of human health. It has strategic alliance with bayer healthcare ag for the use of its technology in the field of animal health. Juvaris ...

Clinical Laserthermia Systems AB (Symbol:CLS B) SWOT Analysis, Strategy, Revenues and Profits

Clinical Laserthermia Systems AB (Symbol:CLS B) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • July 2014
  • by Global Data

... Highlightsclinical laserthermia systems ab (cls) is a medical device company. It develops and markets products for the treatment of solid cancer tumors. The company's flagship product tranberg cancer immunotherapy system consists ...

Argos Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Argos Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

... Renal cell carcinoma and mrcc and ags-004 for the treatment of hiv. The company's arcelis personalized immunotherapy technology optimizes treatment to fight the current manifestation of each patient ...

Immunotherapy in Oncology Drug Pipeline Update 2014

Immunotherapy in Oncology Drug Pipeline Update 2014

  • $ 3 675
  • Industry report
  • July 2014
  • by Bioseeker

... immunotherapy in oncology drug pipeline update 2014 cancer immunotherapy offers an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity ...

Immunotherapy in Oncology: Drug Pathway Analyzer 2014

Immunotherapy in Oncology: Drug Pathway Analyzer 2014

  • $ 3 675
  • Industry report
  • July 2014
  • by Bioseeker

... immunotherapy drug-pathway relationship by using up to four different pathway sources and further refine your analysis with up to 20 different pipeline parameters, including parameters such as presence ...

MarketVIEW: allergic immunotherapies

MarketVIEW: allergic immunotherapies

  • $ 4 495
  • Industry report
  • July 2014
  • by VacZine Analytics Group Of Assay Advantage Ltd

... immunotherapies methodology: allergic rhinitis prevalence and severity methodology: sensitization to inhaled allergens methodology: treatment inputs methodology: treatment pricing ...

About 900 reports for Immunotherapy

Download Unlimited Documents from Trusted Public Sources

Alk - Annual Report, June 2014

  • Alk Releases its Annual Report 2013
  • June 2014
    73 pages
  • Denmark  

    Europe  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.